Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Among authors: morfini m. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.
Martinowitz U, Shapiro A, Quon DV, Escobar M, Kempton C, Collins PW, Chowdary P, Makris M, Mannucci PM, Morfini M, Valentino LA, Gomperts E, Lee M. Martinowitz U, et al. Among authors: morfini m. Haemophilia. 2012 Nov;18(6):881-7. doi: 10.1111/j.1365-2516.2012.02897.x. Epub 2012 Jul 5. Haemophilia. 2012. PMID: 22764744 Clinical Trial.
When should prophylaxis therapy in inhibitor patients be considered?
Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, Santagostino E, Blanchette V. Young G, et al. Among authors: morfini m. Haemophilia. 2011 Sep;17(5):e849-57. doi: 10.1111/j.1365-2516.2011.02494.x. Epub 2011 Mar 21. Haemophilia. 2011. PMID: 21418444 Review.
Pharmacokinetics of factor VIII and factor IX.
Morfini M. Morfini M. Haemophilia. 2003 May;9 Suppl 1:94-9; discussion 100. doi: 10.1046/j.1365-2516.9.s1.8.x. Haemophilia. 2003. PMID: 12709044 Review.
The pharmacokinetics of coagulation factors.
Lee M, Morfini M, Negrier C, Chamouard V. Lee M, et al. Among authors: morfini m. Haemophilia. 2006 Jul;12 Suppl 3:1-7. doi: 10.1111/j.1365-2516.2006.01253.x. Haemophilia. 2006. PMID: 16683990 Review.
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A.
Martinowitz U, Bjerre J, Brand B, Klamroth R, Misgav M, Morfini M, Santagostino E, Tiede A, Viuff D. Martinowitz U, et al. Among authors: morfini m. Haemophilia. 2011 Nov;17(6):854-9. doi: 10.1111/j.1365-2516.2011.02495.x. Epub 2011 Mar 28. Haemophilia. 2011. PMID: 21443634 Clinical Trial.
271 results